156 related articles for article (PubMed ID: 37266140)
1. Long COVID syndrome after SARS-CoV-2 survival in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Wieteska-Miłek M; Kuśmierczyk-Droszcz B; Betkier-Lipińska K; Szmit S; Florczyk M; Zieliński P; Hoffman P; Krzesińki P; Kurzyna M
Pulm Circ; 2023 Apr; 13(2):e12244. PubMed ID: 37266140
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of COVID-19 in patients vaccinated and unvaccinated against SARS-CoV-2 and suffering from pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Wieteska-Miłek M; Kuśmierczyk-Droszcz B; Ryczek R; Szmit S; Florczyk M; Mańczak R; Betkier-Lipińska K; Hoffman P; Krzesiński P; Torbicki A; Kurzyna M
Pol Arch Intern Med; 2023 May; 133(5):. PubMed ID: 36602859
[TBL] [Abstract][Full Text] [Related]
3. Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2.
Caguana-Vélez OA; Khilzi K; Piccari L; Rodríguez-Sevilla JJ; Badenes-Bonet D; Gonzalez-Garcia J; Chalela R; Arita M; Rodó-Pin A; Herranz A; Admetlló M; Villar-Garcia J; Molina L; Zuccarino F; Gea J; Balcells E; Rodríguez-Chiaradia DA
Respiration; 2024; 103(2):79-87. PubMed ID: 38325355
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination.
Wieteska-Miłek M; Szmit S; Florczyk M; Kuśmierczyk-Droszcz B; Ryczek R; Kurzyna M
Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960141
[TBL] [Abstract][Full Text] [Related]
5. Clinical observations of COVID-19 infection in patients with chronic thromboembolic pulmonary hypertension.
Kamenskaya OV; Loginova IY; Klinkova AS; Lomivorotov VV; Chernyavsky AM
Kardiologiia; 2021 Jul; 61(6):28-34. PubMed ID: 34311685
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Insights from a referral center in Portugal.
Santos M; Gomes A; Cruz C; Rocha J; Ricardo M; Gonçalves F; Carvalho L; Vicente M; Melo A; Reis A
Rev Port Cardiol (Engl Ed); 2018 Sep; 37(9):749-757. PubMed ID: 30144959
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension.
van Thor MCJ; Ten Klooster L; Snijder RJ; Post MC; Mager JJ
Int J Cardiol Heart Vasc; 2019 Mar; 22():163-168. PubMed ID: 30859124
[TBL] [Abstract][Full Text] [Related]
8. Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension.
Saxer S; Lichtblau M; Berlier C; Hasler ED; Schwarz EI; Ulrich S
Lung; 2019 Oct; 197(5):617-625. PubMed ID: 31263960
[TBL] [Abstract][Full Text] [Related]
9. Risk Factor Profiles Achieved with Medical Therapy in Prevalent Patients with Pulmonary Arterial and Distal Chronic Thromboembolic Pulmonary Hypertension.
Bartenstein P; Saxer S; Appenzeller P; Lichtblau M; Schwarz EI; Ulrich S
Respiration; 2018; 96(2):127-137. PubMed ID: 29642071
[TBL] [Abstract][Full Text] [Related]
10. Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension - Symptoms and Impact (PAH-SYMPACT™) questionnaire in patients with chronic thromboembolic pulmonary hypertension (CTEPH): a qualitative interview study.
Currie B; Davies E; Beaudet A; Stassek L; Kleinman L
J Patient Rep Outcomes; 2021 Jun; 5(1):51. PubMed ID: 34185198
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe.
Skride A; Sablinskis K; Lejnieks A; Rudzitis A; Lang I
Pulm Circ; 2018; 8(3):2045894018780521. PubMed ID: 29767576
[TBL] [Abstract][Full Text] [Related]
12. The Outcome of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the COVID-19 Pandemic.
Serati A; Keshmiri MS; Shafaghi S; Mohammad MM; Kashani BS; Naghashzadeh F; Mohamadifar A; Shafaghi M; Noorali S; Hajimoradi M; Astani B; Aghdasi S; Riahi M; Alavi S; Malek R; Movahed MR
Crit Pathw Cardiol; 2023 Jun; 22(2):60-64. PubMed ID: 37220659
[TBL] [Abstract][Full Text] [Related]
13. Disease characteristics and clinical outcome over two decades from the Swiss pulmonary hypertension registry.
Appenzeller P; Lichtblau M; Berlier C; Aubert JD; Azzola A; Fellrath JM; Geiser T; Lador F; Pohle S; Opitz I; Schwerzmann M; Stricker H; Tamm M; Saxer S; Ulrich S
Pulm Circ; 2022 Jan; 12(1):e12001. PubMed ID: 35506112
[TBL] [Abstract][Full Text] [Related]
14. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.
Montani D; Certain MC; Weatherald J; Jaïs X; Bulifon S; Noel-Savina E; Nieves A; Renard S; Traclet J; Bouvaist H; Riou M; de Groote P; Moceri P; Bertoletti L; Favrolt N; Guillaumot A; Jutant EM; Beurnier A; Boucly A; Ebstein N; Jevnikar M; Pichon J; Keddache S; Preda M; Roche A; Solinas S; Seferian A; Reynaud-Gaubert M; Cottin V; Savale L; Humbert M; Sitbon O;
Am J Respir Crit Care Med; 2022 Sep; 206(5):573-583. PubMed ID: 35549842
[No Abstract] [Full Text] [Related]
16. Plasma markers in pulmonary hypertension subgroups correlate with patient survival.
Koudstaal T; van Uden D; van Hulst JAC; Heukels P; Bergen IM; Geenen LW; Baggen VJM; van den Bosch AE; van den Toorn LM; Chandoesing PP; Kool M; Boersma E; Hendriks RW; Boomars KA
Respir Res; 2021 May; 22(1):137. PubMed ID: 33947407
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective.
Koudstaal T; Boomars KA; Kool M
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32092864
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.
Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
Curr Med Res Opin; 2011 Sep; 27(9):1763-8. PubMed ID: 21793646
[TBL] [Abstract][Full Text] [Related]
19. Does combination therapy work in chronic thromboembolic pulmonary hypertension?
van Thor MCJ; Snijder RJ; Kelder JC; Mager JJ; Post MC
Int J Cardiol Heart Vasc; 2020 Aug; 29():100544. PubMed ID: 32518816
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.
Nasserie T; Hittle M; Goodman SN
JAMA Netw Open; 2021 May; 4(5):e2111417. PubMed ID: 34037731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
